XML 43 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Details-4) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Beginning balance, $ (58,797) $ (69,598) $ (64,628) $ (72,346)
Realized and unrealized gains (losses):        
Included in regulatory liabilities (assets) 9,448 2,743 15,279 5,490
Included in other comprehensive income 0 0 0 0
Included in earnings 651 (44) 7,218 (1,351)
Included in current assets (185) (123) (185) (123)
Purchases 6,828 6,162 13,634 11,724
Sales 0 0 (60) (2)
Issuances 0 0 0 0
Settlements (7,294) (5,996) (20,607) (10,248)
Transfers in and/or out of level 3 0 0 0 0
Ending balance, (49,349) (66,856) (49,349) (66,856)
Total gains (losses) included in earnings attributed to the change in unrealized gains (losses) related to assets and liabilities 0 [1] 0 [1] 0 [1] 0 [1]
Purchased Power Expense [Member]
       
Realized and unrealized gains (losses):        
Included in earnings $ 651 [1] $ (44) [1] $ 7,218 [1] $ (1,351) [1]
[1]

MGE's exchange-traded derivative contracts, over-the-counter party transactions, ten-year purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset with a corresponding regulatory asset or liability.